14
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Effects of naphthalene and naphthalene metabolites on the in vitro humoral immune response

&
Pages 53-67 | Received 11 Sep 1989, Accepted 06 Jan 1990, Published online: 15 Oct 2009
 

Abstract

Naphthalene‐induced pulmonary and renal toxicity and polycyclic aromatic hydrocarbon‐induced carcinogenesis are known to be mediated by their reactive metabolites. Subchronic exposure (90 d) of mice to naphthalene does not alter humoral and cellular‐mediated immune responses, whereas polycyclic aromatic hydrocarbons, such as benzo[a]pyrene and 7,12‐dimethylbenzanthracene, are known to be immuno‐suppressive. To understand these differences, the antibody‐forming cell (AFC) responses of splenocyte cultures exposed to naphthalene (2, 20, and 200 μM) were evaluated. At these concentrations, the antibody‐forming cell response to sheep red blood cells (RBC) was not affected. To determine if reactive metabolites of naphthalene were immunosuppressive, splenocytes were exposed to naphthalene metabolites by direct addition or through the use of a metabolic activation system. The addition of 1‐naphthol (70 and 200 μM) and 1,4‐naphthoquinone (2, 7, and 20 μM) resulted in a decreased antibody‐forming cell response. Suppression of AFC responses was also obtained by culturing splenocytes with liver S9 and naphthalene. Since splenic metabolism of naphthalene to nonimmunosuppressive metabolites may account for the absence of immunotoxicity, the types of naphthalene metabolites generated by splenic microsomes were determined. It was observed that splenic microsomes were unable to generate any detectable naphthalene metabolites, whereas liver microsomes were able to generate both 1,2‐naphthalene diol and 1‐naphthol. Thus, the absence of an immunosuppressive effect by naphthalene exposure may be related to the inability of splenocytes to metabolize naphthalene. Moreover, the concentration of naphthalene metabolites generated within the liver that may diffuse to the spleen may be inadequate to produce immunotoxicity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.